vs

Side-by-side financial comparison of LandBridge Co LLC (LB) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). LandBridge Co LLC runs the higher net margin — 14.2% vs -26.0%, a 40.1% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -23.3%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-9.2M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

LB vs PETS — Head-to-Head

Bigger by revenue
LB
LB
1.4× larger
LB
$56.8M
$40.7M
PETS
Growing faster (revenue YoY)
LB
LB
+78.8% gap
LB
55.6%
-23.3%
PETS
Higher net margin
LB
LB
40.1% more per $
LB
14.2%
-26.0%
PETS
More free cash flow
LB
LB
$131.3M more FCF
LB
$122.0M
$-9.2M
PETS
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
LB
LB
PETS
PETS
Revenue
$56.8M
$40.7M
Net Profit
$8.1M
$-10.6M
Gross Margin
23.3%
Operating Margin
60.0%
-25.7%
Net Margin
14.2%
-26.0%
Revenue YoY
55.6%
-23.3%
Net Profit YoY
-83.7%
-1392.6%
EPS (diluted)
$0.24
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LB
LB
PETS
PETS
Q4 25
$56.8M
$40.7M
Q3 25
$50.8M
$44.4M
Q2 25
$47.5M
$51.2M
Q1 25
$44.0M
$50.8M
Q4 24
$36.5M
$52.0M
Q3 24
$28.5M
$58.0M
Q2 24
$26.0M
$66.2M
Q1 24
$19.0M
$65.1M
Net Profit
LB
LB
PETS
PETS
Q4 25
$8.1M
$-10.6M
Q3 25
$8.1M
$-8.5M
Q2 25
$7.5M
$-34.2M
Q1 25
$6.5M
$-11.6M
Q4 24
$49.3M
$-707.0K
Q3 24
$2.7M
$2.3M
Q2 24
$-57.7M
$3.8M
Q1 24
$10.8M
$-5.0M
Gross Margin
LB
LB
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
LB
LB
PETS
PETS
Q4 25
60.0%
-25.7%
Q3 25
60.8%
-18.9%
Q2 25
60.0%
-66.7%
Q1 25
57.0%
-11.9%
Q4 24
49.4%
-0.9%
Q3 24
11.2%
1.0%
Q2 24
-197.4%
6.6%
Q1 24
71.1%
-5.9%
Net Margin
LB
LB
PETS
PETS
Q4 25
14.2%
-26.0%
Q3 25
15.9%
-19.2%
Q2 25
15.8%
-66.7%
Q1 25
14.7%
-22.9%
Q4 24
135.2%
-1.4%
Q3 24
9.3%
4.0%
Q2 24
-222.1%
5.7%
Q1 24
56.7%
-7.7%
EPS (diluted)
LB
LB
PETS
PETS
Q4 25
$0.24
$-0.50
Q3 25
$0.26
$-0.41
Q2 25
$0.24
$-1.65
Q1 25
$0.20
$-0.56
Q4 24
$-0.03
Q3 24
$-0.04
$0.11
Q2 24
$0.18
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LB
LB
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$30.7M
$26.9M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$340.3M
$32.8M
Total Assets
$1.4B
$88.0M
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LB
LB
PETS
PETS
Q4 25
$30.7M
$26.9M
Q3 25
$28.3M
$36.1M
Q2 25
$20.3M
$41.1M
Q1 25
$14.9M
$54.7M
Q4 24
$37.0M
$50.1M
Q3 24
$14.4M
$52.0M
Q2 24
$24.6M
$46.0M
Q1 24
$55.3M
Total Debt
LB
LB
PETS
PETS
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
LB
LB
PETS
PETS
Q4 25
$340.3M
$32.8M
Q3 25
$272.0M
$43.1M
Q2 25
$266.4M
$51.5M
Q1 25
$217.0M
$85.1M
Q4 24
$211.8M
$96.2M
Q3 24
$97.2M
$96.4M
Q2 24
$296.4M
$93.5M
Q1 24
$162.3M
$96.7M
Total Assets
LB
LB
PETS
PETS
Q4 25
$1.4B
$88.0M
Q3 25
$1.1B
$100.3M
Q2 25
$1.1B
$109.8M
Q1 25
$1.0B
$148.7M
Q4 24
$1.0B
$144.8M
Q3 24
$689.9M
$146.0M
Q2 24
$710.5M
$152.7M
Q1 24
$169.9M
Debt / Equity
LB
LB
PETS
PETS
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LB
LB
PETS
PETS
Operating Cash FlowLast quarter
$126.3M
$-9.2M
Free Cash FlowOCF − Capex
$122.0M
$-9.2M
FCF MarginFCF / Revenue
214.9%
-22.7%
Capex IntensityCapex / Revenue
7.5%
0.1%
Cash ConversionOCF / Net Profit
15.68×
TTM Free Cash FlowTrailing 4 quarters
$207.7M
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LB
LB
PETS
PETS
Q4 25
$126.3M
$-9.2M
Q3 25
$34.9M
$-2.2M
Q2 25
$37.3M
$-12.3M
Q1 25
$15.9M
$7.0M
Q4 24
$67.6M
$-1.2M
Q3 24
$7.5M
$7.4M
Q2 24
$16.0M
$-8.5M
Q1 24
$17.2M
$7.1M
Free Cash Flow
LB
LB
PETS
PETS
Q4 25
$122.0M
$-9.2M
Q3 25
$33.7M
$-4.8M
Q2 25
$36.1M
$-13.6M
Q1 25
$15.8M
$4.6M
Q4 24
$66.7M
$-1.9M
Q3 24
$7.1M
$6.1M
Q2 24
$15.7M
$-9.2M
Q1 24
$17.1M
$5.9M
FCF Margin
LB
LB
PETS
PETS
Q4 25
214.9%
-22.7%
Q3 25
66.3%
-10.8%
Q2 25
75.9%
-26.5%
Q1 25
36.0%
9.1%
Q4 24
182.6%
-3.7%
Q3 24
25.1%
10.6%
Q2 24
60.4%
-13.9%
Q1 24
90.1%
9.0%
Capex Intensity
LB
LB
PETS
PETS
Q4 25
7.5%
0.1%
Q3 25
2.3%
5.9%
Q2 25
2.6%
2.5%
Q1 25
0.2%
4.7%
Q4 24
2.7%
1.5%
Q3 24
1.1%
2.2%
Q2 24
1.4%
1.0%
Q1 24
0.5%
1.9%
Cash Conversion
LB
LB
PETS
PETS
Q4 25
15.68×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
2.80×
3.18×
Q2 24
-2.27×
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LB
LB

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons